Evidence map›Paper›PMID 20725864›Full record

ReviewImmunologic research2010

Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

K Grovit-Ferbas, M E Harris-White

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Induce Pathological Pain through Wnt5a-Mediated Neuroinflammation in Aging Mice.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  5. Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  6. Article
  7. Article
  8. HIV Vpr controls CNS metabolism.Cell cycle (Georgetown, Tex.) · 2016
    Article
  9. Review
  10. Imaging neuroinflammation? A perspective from MR spectroscopy.Brain pathology (Zurich, Switzerland) · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K Grovit-FerbasUCLA AIDS Institute, Department of Medicine, University of California-Los Angeles, 11301 Wilshire Blvd., Los Angeles, CA 90073, USA. kferbas@ucla.edu
M E Harris-White
UCLA Health · USVA Greater Los Angeles Healthcare System · US

Funding

Carrier Mediated Uptake of ABeta In Vivo &In VitroR01AG022080 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HARRIS-WHITE, MARNI E · 2003 to 2007
$1.3M
NIA NIH HHS R01 AG022080
6 · The paper itself

Abstract

It is estimated that half of HIV-infected adults and children will present at one time during their disease course with a neurologic disorder. The neurologic sequelae of HIV infection arise as a direct result of viral replication as well as from the subsequent neuroinflammatory processes. HIV enters the CNS early in infection and resides primarily in long-lived perivascular macrophages and microglia. CNS immunosurveillance is an integral part of normal brain function. Circulating lymphocytes play a vital role in support of brain plasticity under normal and traumatic circumstances. Malfunctions of this immunologic niche can impair brain homeostasis, resulting in neural impairment. Combination therapies that lower CNS viral load and improve immune homeostasis and neuroprotection will be required to address the neuropathogenesis of HIV infection.

Indexed as

AIDS Dementia ComplexAnimalsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBrainHIVHumansImmunologic SurveillanceMacrophagesMicrogliaNeuritisNeuroprotective AgentsViral LoadVirus ReplicationAnti-HIV AgentsNeuroprotective Agents

Identifiers

PMID20725864
OpenAlexW2010040953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.